Acasti Pharma Inc Marktkapitalisierung
Was ist das Marktkapitalisierung von Acasti Pharma Inc?
Marktkapitalisierung von Acasti Pharma Inc ist $15.38M
Was ist die Definition von Marktkapitalisierung?
Die Marktkapitalisierung ist der Marktwert zu einem Zeitpunkt, zu dem die Aktien eines börsennotierten Unternehmens im Umlauf sind, und ist gleich dem Aktienkurs zu diesem Zeitpunkt multipliziert mit der Anzahl der im Umlauf befindlichen Aktien .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Marktkapitalisierung von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acasti Pharma Inc
Was macht Acasti Pharma Inc?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Unternehmen mit marktkapitalisierung ähnlich Acasti Pharma Inc
- DelMar Pharmaceuticals hat Marktkapitalisierung von $15.35M
- Rubius Therapeutics Inc hat Marktkapitalisierung von $15.36M
- Masivo Silver Corp hat Marktkapitalisierung von $15.36M
- IXICO plc hat Marktkapitalisierung von $15.37M
- Beautiful China hat Marktkapitalisierung von $15.37M
- Commercial Syn Bags hat Marktkapitalisierung von $15.38M
- Acasti Pharma Inc hat Marktkapitalisierung von $15.38M
- Kkalpana Industries (India) hat Marktkapitalisierung von $15.39M
- Valdor Technology International hat Marktkapitalisierung von $15.40M
- Walker Crips plc hat Marktkapitalisierung von $15.42M
- Dragon-Ukrainian Properties & Development plc hat Marktkapitalisierung von $15.42M
- Siyata Mobile hat Marktkapitalisierung von $15.43M
- Estrella Resources hat Marktkapitalisierung von $15.44M